ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Rosetta Genomics Ltd (EM)

Rosetta Genomics Ltd (EM) (ROSGQ)

0.000001
0.00
( 0.00% )
更新日時: 09:00:00

Rosetta Genomics Ltd (EM) (ROSGQ) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.000001
( - )
買値
0.00
売値
0.00
出来高
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.0002
時価総額
前日終値
0.000001
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 8,198
発行済株式数
5,929,860
配当利回り
PER
-
1 株当たり利益 (EPS)
-6.41
歳入
2.86M
純利益
-13.39M

Rosetta Genomics Ltd (EM) について

Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company’s microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; ... Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company’s microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel. 詳細を表示

セクター
Healthcare
業界
Medical Diagnostics & Screening
ウェブサイト
本社
Rehovot, Israel
設立
2026
Rosetta Genomics Ltd (EM) is listed in the Healthcare sector of the その他OTC with ticker ROSGQ. The last closing price for Rosetta Genomics (EM) was US$0. Over the last year, Rosetta Genomics (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0002.

Rosetta Genomics (EM) currently has 5,929,860 shares in issue. The market capitalisation of Rosetta Genomics (EM) is US$5.93 . Rosetta Genomics (EM) has a price to earnings ratio (PE ratio) of 0.

ROSGQ 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
12-9.9E-5-990.00010.00011.0E-634631.0E-6CS
26001.0E-60.00021.0E-618356.387E-5CS
52-9.9E-5-990.00010.00021.0E-627939.279E-5CS
156-9.9E-5-990.00010.00021.0E-644196.27E-5CS
260-0.065449-99.99847211610.065450.08991.0E-692770.02291327CS

ROSGQ - Frequently Asked Questions (FAQ)

What is the current Rosetta Genomics Ltd (EM) share price?
The current share price of Rosetta Genomics Ltd (EM) is US$ 0.000001
How many Rosetta Genomics Ltd (EM) shares are in issue?
Rosetta Genomics Ltd (EM) has 5,929,860 shares in issue
What is the market cap of Rosetta Genomics Ltd (EM)?
The market capitalisation of Rosetta Genomics Ltd (EM) is USD 5.93
What is the 1 year trading range for Rosetta Genomics Ltd (EM) share price?
Rosetta Genomics Ltd (EM) has traded in the range of US$ 0.000001 to US$ 0.0002 during the past year
What is the cash to sales ratio of Rosetta Genomics Ltd (EM)?
The cash to sales ratio of Rosetta Genomics Ltd (EM) is 0
What is the registered address of Rosetta Genomics Ltd (EM)?
The registered address for Rosetta Genomics Ltd (EM) is 10 Plaut Street, Rehovot, 76706
What is the Rosetta Genomics Ltd (EM) website address?
The website address for Rosetta Genomics Ltd (EM) is www.rosettagenomics.com
Which industry sector does Rosetta Genomics Ltd (EM) operate in?
Rosetta Genomics Ltd (EM) operates in the Medical Diagnostics & Screening sector

ROSGQ 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

ROSGQ Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock